Published on September 24, 2009 at 7:52 AM
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that the Company’s CEO, Eugene Seymour, MD, MPH has been invited as a panelist at the 2nd Annual Livingston Healthcare Summit on September 24th, 2009 in New York City.
Dr. Seymour will join other industry panelists in the “Drug Discovery and Development” session to discuss early to mid-stage financing and pharmaceutical alliance challenges and trends. The panelists and participants include pharmaceutical and biotech decision makers and executives, investors, government and regulatory agency representatives from a number of countries.
This is a unique, by invitation conference, designed to bring together key stakeholders from pharmaceutical, finance and investment, business strategy, as well as governmental science and regulatory segments, according to Conference Chair, Mostafa Analoui, PhD, Head of Healthcare and Life Sciences at Livingston Securities.
“This is an important opportunity to network with significant decision-makers in our industry,” said Dr. Seymour.
http://www.nanoviricides.com/